Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Surface Oncology IncfiledCriticalNovartis Ag
Publication of AR119639A1publicationCriticalpatent/AR119639A1/es
Se divulgan moléculas de anticuerpo que se unen a CD73. Las moléculas de anticuerpo anti-CD73 pueden usarse para tratar, prevenir y/o diagnosticar el cáncer.
ARP180101745A2017-06-222018-06-22Moléculas de anticuerpo para cd73 y sus usos
AR119639A1
(es)